CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma

Published:2018-11-28 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Morandi Fabio,Horenstein Alberto L.,Costa Federica,Giuliani Nicola,Pistoia Vito,Malavasi Fabio

Funder

Associazione Italiana per la Ricerca sul Cancro

International Myeloma Foundation

Compagnia di San Paolo

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Multiple myeloma: evolving genetic events and host interactions;Kuehl;Nat Rev Cancer,2002

2. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;Br J Haematol.,2003

3. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management;Kyle;Leukemia,2010

4. The molecular classification of multiple myeloma;Zhan;Blood,2006

5. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome;Avet-Loiseau;Blood,2007

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2025 update on clinical trials in immune thrombocytopenia;American Journal of Hematology;2024-08-06

2. Lymphocyte profile in peripheral blood of patients with multiple myeloma;Annals of Hematology;2024-06-04

3. From spear to trident: Upgrading arsenal of CAR-T cells in the treatment of multiple myeloma;Heliyon;2024-05

4. A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ–induced CD38 expression;Blood;2024-04-18

5. Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials;Journal of Personalized Medicine;2024-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3